1. Home
  2. FTEK vs MREO Comparison

FTEK vs MREO Comparison

Compare FTEK & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fuel Tech Inc.

FTEK

Fuel Tech Inc.

HOLD

Current Price

$1.37

Market Cap

46.1M

Sector

Industrials

ML Signal

HOLD

Logo Mereo BioPharma Group plc

MREO

Mereo BioPharma Group plc

HOLD

Current Price

$0.31

Market Cap

52.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTEK
MREO
Founded
1987
2015
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Pollution Control Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
46.1M
52.5M
IPO Year
1997
2017

Fundamental Metrics

Financial Performance
Metric
FTEK
MREO
Price
$1.37
$0.31
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$1.50
AVG Volume (30 Days)
187.9K
4.2M
Earning Date
05-05-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
16.67
EPS
N/A
N/A
Revenue
$30,467,000.00
$500,000.00
Revenue This Year
$14.17
$5,184.20
Revenue Next Year
$11.62
$55.51
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.17
$0.20
52 Week High
$3.64
$2.94

Technical Indicators

Market Signals
Indicator
FTEK
MREO
Relative Strength Index (RSI) 39.10 51.94
Support Level $1.17 $0.22
Resistance Level $1.52 $0.36
Average True Range (ATR) 0.06 0.05
MACD -0.01 0.01
Stochastic Oscillator 0.00 59.37

Price Performance

Historical Comparison
FTEK
MREO

About FTEK Fuel Tech Inc.

Fuel Tech Inc is a technology provider of boiler optimization, efficiency improvement, and air pollution reduction to utility and industrial customers. The company operates in two segments, Air Pollution Control and Fuel Chem. The Air Pollution Control technology segment includes technologies to reduce NOx emissions in flue gas from boilers, incinerators, furnaces, and other stationary combustion sources. The Fuel Chem technology segment uses chemical processes in combination with Computational Fluid Dynamics and Chemical Kinetics Modeling for boiler modeling for the control of slagging, fouling, corrosion, opacity and other sulfur trioxide-related issues in furnaces and boilers through the addition of chemicals into the furnace using TIFI Targeted In-Furnace Injection technology.

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

Share on Social Networks: